Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We already know the cause of death. It was a massive heart attack. Interesting that he was working on a technology to help people with heart problems, no?
One of the strongest momo plays going is ACTC- Strong Buy
See the technical analysis and read the full story!
http://biomedreports.com/2010121661472/qstrong-buyq-recommendations-mark-the-chart-of-bullish-stem-cell-penny-stock.html
"Strong Buy" for stem cell penny stock ACTC!
Read the full report:
http://biomedreports.com/2010121661472/qstrong-buyq-recommendations-mark-the-chart-of-bullish-stem-cell-penny-stock.html
Agreed. That chart formed a VERY bullish candle today.
ACTC News! European Pharma may partner with them.
The shorts are going to have to start covering now.
Link:
http://finance.bnet.com/bnet/news/read?GUID=16032650&tag=content;col1
NEWS!! European Pharma rumors linked to ACTC!
ACTC is on the regshow full of naked shorts. Now they are going to have to cover!!!
http://finance.bnet.com/bnet/news/read?GUID=16032650&tag=content;col1
WDST is going to move on this news!
http://finance.yahoo.com/news/Regenicin-to-Present-at-Event-prnews-2690373881.html?x=0&.v=1
Guess Garza was right. Company's official announcement is out:
http://finance.yahoo.com/news/Regenicin-to-Present-at-Event-prnews-2690373881.html?x=0&.v=1
Yes.. But like I said.. We won't see that until some sort of FDA approval because even the military/government can't order as much as they would like without FDA approval. After that, Im with you. Share prices could be much higher- although many other questions remain about what % of profits they get to keep, etc.
I think a $4 price target once the technology is FDA approved is realistic, but I'm not so sure that will be the case in the near term. I think there is too much "paper" out there that will be sold after the stock hits its year highs of $2.50 or so. You can tell by the way the stock has acted that someone involved in the initial financing is still dumping shares.
I would agree with you except that this is Israel. The same country that has been talking about this company and drug for some time now. And not only that, but they live in constant fear of nuclear attack. I think they will order the drug very soon.
Just saw that volume has picked up on this. Anyone know what is going on?
Actually according to Garza's latest article, the next catalyst should be a small grant followed by a big grant followed by an order from Israel.
See it:
http://biomedreports.com/2010101558363/unfounded-fear-of-dillution-hit-cleveland-biolabs.html
This thing just keeps kreeping higher and higher. Garza was right! I say 2 weeks before we hear the shoe drop.
Well, well, well.. Looks like Sykes was wrong again. This thing is poppin' on a great "pump". LOL!
This is a huge winner. Garza from Biomedreports.com has been on this horse for a while and he called a winner here. Now others are jumping on the bandwagon saying this is a $60 stock in the next 2 years: Look at this report
Where did this come from?
NBS will fly given all the short interest and a pending news conference:
Details and report here:
http://biomedreports.com/articles/most-popular/55319-shorts-already-starting-to-cover-their-positions-in-neostem.html
Shorts already starting to cover their positions in Neostem
New story posted here:
http://biomedreports.com/articles/most-popular/55319-shorts-already-starting-to-cover-their-positions-in-neostem.html
I think the stock goes up regardless of what anyone writes. It's a solid technology and company. The "future" of medicine.
Biomed stands by their story about RXII!!! Both Adam FartStain and Timothy Sykes are going down! Last time Sykes tried to short one of these Biomed picks his subscribers got killed.
Now Biomed is doing exactly what they did when he tried to get his shorts to jump on BJGP at $6. Biomed stood by their story and the stock jumped up again. It's at $8 bucks now.
See the report:
http://biomedreports.com/articles/most-popular/54354-up-another-72-whod-a-thunk.html
Alert- BJGP buyout set to be announced
http://www.tradingmarkets.com/news/stock-alert/bjgp_announcement-pending-on-buyout-deal-1087955.html
I agree. BJGP looks like a big winner. Rising after bear raid and news could come as early as today.
BJPG running back up to $9 on buyout reports.
http://biomedreports.com/articles/most-popular/48040-bjgp-still-in-play-after-bear-raid.html
BJGP ran big on Monday. About to run some more!
Here is the scoop:
http://www.tradingmarkets.com/news/stock-alert/bjgp_bjgp-subject-of-takeover-talk-1050334.html
BJGP subject of takeover talk
http://www.tradingmarkets.com/news/stock-alert/bjgp_bjgp-subject-of-takeover-talk-1050334.html
BJGP running on buyout news!
Shares of BJGP began to rise in afternoon trading on Monday after published reports confirmed that BMP Sunstone Corporation (NasdaqGM: BJGP) is the subject of loud takeover chatter.
The stock was one of the most actively traded stocks in the healthcare sector according to Google Finance, and reports are indicating a buyout price between $9 and $10 per share.
Officials at the company would not comment on the speculation, but sources indicate that the company will be purchased by a privately held company within the next few days.
Shares of BJGP are still trading below the target buyout price, but have been rising steadily during the last few trading sessions.
BMP Sunstone Corporation (BMP Sunstone) is a specialty pharmaceutical company engaged in the development, manufacture, and sales of over-the-counter (OTC), medicinal brands for women and children in China.
Other companies in the Healthcare Supply Chain Services include Cardinal Health, Inc. (NYSE: CAH) and AmerisourceBergen Corp.(Public, NYSE:ABC).
BJGP buyout rumors Shares flying!
Stock is second highest gainer in the healthcare sector:
http://www.google.com/finance?catid=64715132
Buyout price is $9+ per share.
Story reported by theflyonthewall.
BJGP buyout rumors confirmed. Shares flying!
Stock is second highest gainer in the healthcare sector:
http://www.google.com/finance?catid=64715132
And the buyout price is $9+ per share.
Story here:
http://www.smallcapnetwork.com/BMP-Sunstone-Corp-NASDAQ-BJGP-a-confirmed-buyout-target/s/article/view/p/mid/5/id/53/
ILNS News Out!
Four Big Pharmas Bet Big on Intellect Neurosciences' Platform to Treat Alzheimer's Disease
link:
http://www.marketwatch.com/story/four-big-pharmas-bet-big-on-intellect-neurosciences-platform-to-treat-alzheimers-disease-2010-07-14?reflink=MW_news_stmp
News: Four Big Pharmas Bet Big on ILNS
Penny stock gets big deal. Here is the link:
http://www.marketwatch.com/story/four-big-pharmas-bet-big-on-intellect-neurosciences-platform-to-treat-alzheimers-disease-2010-07-14?reflink=MW_news_stmp
ILNS is being picked by several newsletters and news sources as the next big penny play.
Check it out:
http://investor.news.com/bnet/news/read?GUID=13791527
http://www.thepennystockpicks.com/ilns-invest-in-a-billion-dollar-drug-for-pennies/
http://biomedreports.com/articles/subscriber-only-content/47007-this-stock-is-finally-ready-to-run.html
Meanwhile the stock has gone up 12 and 20% respectively in the last two sessions. This is going back to $.15 and beyond, IMHO.
CBS Marketwatch Article on ILNS
http://investor.news.com/bnet/news/read?GUID=13791527
RXII keeps climbing due to takeover/merger talk:
http://studio-5.financialcontent.com/mng-ba.mercurynews/news/read?GUID=13402870
So does NWBO!
Denver Post on RXII and NWBO!
Buyout coming:
http://finance.denverpost.com/mng-denver/news/read?GUID=13402870
Stock up on takeover rumors following report:
http://finance.sfgate.com/hearst.sfgate/news/read?GUID=13402870
NWBO subject of merger or acquisition rumor. Shares flying!
http://finance.sfgate.com/hearst.sfgate/news/read?GUID=13402870